Literature DB >> 27208764

Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned.

David van Duin1, David L Paterson2.   

Abstract

Multidrug resistant (MDR) bacteria are one of the most important threats to public health. Typically, MDR bacteria are associated with nosocomial infections. However, some MDR bacteria have become prevalent causes of community-acquired infections. The spread of MDR bacteria into the community is a crucial development, and is associated with increased morbidity, mortality, health care costs, and antibiotic use. Factors associated with community dissemination of MDR bacteria overlap but are distinct from those associated with nosocomial spread. Prevention of further community spread of MDR bacteria is of the utmost importance, and requires a multidisciplinary approach involving all stakeholders.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carbapenem-resistant Enterobacteriaceae; Klebsiella pneumoniae; Readmission; Tigecycline; Transmission

Mesh:

Substances:

Year:  2016        PMID: 27208764      PMCID: PMC5314345          DOI: 10.1016/j.idc.2016.02.004

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  83 in total

1.  Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage.

Authors:  James A McKinnell; Danielle F Kunz; Eric Chamot; Mukesh Patel; Rhett M Shirley; Stephen A Moser; John W Baddley; Peter G Pappas; Loren G Miller
Journal:  Infect Control Hosp Epidemiol       Date:  2012-05-14       Impact factor: 3.254

2.  Carbapenem-resistant Enterobacteriaceae: a potential threat.

Authors:  Mitchell J Schwaber; Yehuda Carmeli
Journal:  JAMA       Date:  2008-12-24       Impact factor: 56.272

Review 3.  The changing epidemiology of resistance.

Authors:  Peter M Hawkey; Annie M Jones
Journal:  J Antimicrob Chemother       Date:  2009-09       Impact factor: 5.790

4.  Impact of isolation on hospital consumer assessment of healthcare providers and systems scores: is isolation isolating?

Authors:  Joan Vinski; Mary Bertin; Zhiyuan Sun; Steven M Gordon; Daniel Bokar; James Merlino; Thomas G Fraser
Journal:  Infect Control Hosp Epidemiol       Date:  2012-03-21       Impact factor: 3.254

5.  Key demographic characteristics of patients with bacteriuria due to extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in a multiethnic community, in North West London.

Authors:  G Gopal Rao; Deepak Batura; Neha Batura; Peder Bo Nielsen
Journal:  Infect Dis (Lond)       Date:  2015-06-16

Review 6.  Reservoirs of Acinetobacter baumannii outside the hospital and potential involvement in emerging human community-acquired infections.

Authors:  Matthieu Eveillard; Marie Kempf; Olivier Belmonte; Hélène Pailhoriès; Marie-Laure Joly-Guillou
Journal:  Int J Infect Dis       Date:  2013-05-11       Impact factor: 3.623

Review 7.  Infection control in cystic fibrosis: cohorting, cross-contamination, and the respiratory therapist.

Authors:  Catherine A O'Malley
Journal:  Respir Care       Date:  2009-05       Impact factor: 2.258

8.  Genotypic and phenotypic profiles of Escherichia coli isolates belonging to clinical sequence type 131 (ST131), clinical non-ST131, and fecal non-ST131 lineages from India.

Authors:  Arif Hussain; Amit Ranjan; Nishant Nandanwar; Anshu Babbar; Savita Jadhav; Niyaz Ahmed
Journal:  Antimicrob Agents Chemother       Date:  2014-09-22       Impact factor: 5.191

9.  Transmission and microevolution of USA300 MRSA in U.S. households: evidence from whole-genome sequencing.

Authors:  Md Tauqeer Alam; Timothy D Read; Robert A Petit; Susan Boyle-Vavra; Loren G Miller; Samantha J Eells; Robert S Daum; Michael Z David
Journal:  mBio       Date:  2015-03-10       Impact factor: 7.867

10.  Pheromone killing of multidrug-resistant Enterococcus faecalis V583 by native commensal strains.

Authors:  Michael S Gilmore; Marcus Rauch; Matthew M Ramsey; Paul R Himes; Sriram Varahan; Janet M Manson; Francois Lebreton; Lynn Ernest Hancock
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-26       Impact factor: 11.205

View more
  98 in total

Review 1.  The global epidemiology of carbapenemase-producing Enterobacteriaceae.

Authors:  David van Duin; Yohei Doi
Journal:  Virulence       Date:  2016-08-11       Impact factor: 5.882

2.  Antibody-Based Immunotherapy To Treat and Prevent Infection with Hypervirulent Klebsiella pneumoniae.

Authors:  Elizabeth Diago-Navarro; Isabel Calatayud-Baselga; Donglei Sun; Camille Khairallah; Inderjit Mann; Amaia Ulacia-Hernando; Brian Sheridan; Meiqing Shi; Bettina C Fries
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

3.  Bacteria: back pain, leg pain and Modic sign-a surgical multicentre comparative study.

Authors:  Peter Fritzell; Christina Welinder-Olsson; Bodil Jönsson; Åsa Melhus; Siv G E Andersson; Tomas Bergström; Hans Tropp; Paul Gerdhem; Olle Hägg; Hans Laestander; Björn Knutsson; Anders Lundin; Per Ekman; Eric Rydman; Mikael Skorpil
Journal:  Eur Spine J       Date:  2019-10-01       Impact factor: 3.134

Review 4.  Risk Factors for Drug-Resistant Cap in Immunocompetent Patients.

Authors:  Francisco Arancibia; Mauricio Ruiz
Journal:  Curr Infect Dis Rep       Date:  2017-03       Impact factor: 3.725

5.  Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study.

Authors:  David van Duin; Cesar A Arias; Lauren Komarow; Liang Chen; Blake M Hanson; Gregory Weston; Eric Cober; Omai B Garner; Jesse T Jacob; Michael J Satlin; Bettina C Fries; Julia Garcia-Diaz; Yohei Doi; Sorabh Dhar; Keith S Kaye; Michelle Earley; Andrea M Hujer; Kristine M Hujer; T Nicholas Domitrovic; William C Shropshire; An Dinh; Claudia Manca; Courtney L Luterbach; Minggui Wang; David L Paterson; Ritu Banerjee; Robin Patel; Scott Evans; Carol Hill; Rebekka Arias; Henry F Chambers; Vance G Fowler; Barry N Kreiswirth; Robert A Bonomo
Journal:  Lancet Infect Dis       Date:  2020-03-06       Impact factor: 25.071

Review 6.  Multi-functionalized nanocarriers targeting bacterial reservoirs to overcome challenges of multi drug-resistance.

Authors:  Maria Hassan Kiani; Muhammad Imran; Abida Raza; Gul Shahnaz
Journal:  Daru       Date:  2020-03-19       Impact factor: 3.117

7.  Charged Metallopolymer-Grafted Silica Nanoparticles for Antimicrobial Applications.

Authors:  Parasmani Pageni; Peng Yang; Yung Pin Chen; Yucheng Huang; Marpe Bam; Tianyu Zhu; Mitzi Nagarkatti; Brian C Benicewicz; Alan W Decho; Chuanbing Tang
Journal:  Biomacromolecules       Date:  2018-01-31       Impact factor: 6.988

Review 8.  Thiazole Ring-A Biologically Active Scaffold.

Authors:  Anthi Petrou; Maria Fesatidou; Athina Geronikaki
Journal:  Molecules       Date:  2021-05-25       Impact factor: 4.411

9.  Antimicrobial Stewardship and Its Impact on the Changing Epidemiology of Polymyxin Use in a South Indian Healthcare Setting.

Authors:  Dipu T Sathyapalan; Jini James; Sangita Sudhir; Vrinda Nampoothiri; Praveena N Bhaskaran; Nandita Shashindran; Jisha Thomas; Preetha Prasanna; Zubair Umer Mohamed; Fabia Edathadathil; Sanjeev Singh; Merlin Moni
Journal:  Antibiotics (Basel)       Date:  2021-04-21

10.  Multidrug Resistance and Molecular Characterization of Streptococcus agalactiae Isolates From Dairy Cattle With Mastitis.

Authors:  Luciana Hernandez; Enriqueta Bottini; Jimena Cadona; Claudio Cacciato; Cristina Monteavaro; Ana Bustamante; Andrea Mariel Sanso
Journal:  Front Cell Infect Microbiol       Date:  2021-04-30       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.